Welspun Corp Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 13, 2025, 10:45 pm

Competitors of Welspun Corp Ltd

All Competitor Stocks of Welspun Corp Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:10 am

Below is a detailed analysis of the quarterly data for Welspun Corp Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3,551.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,925.00 Cr. (Mar 2025) to 3,551.00 Cr., marking a decrease of 374.00 Cr..
• For Expenses, as of Jun 2025, the value is 3,026.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3,465.00 Cr. (Mar 2025) to 3,026.00 Cr., marking a decrease of 439.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 525.00 Cr.. The value appears strong and on an upward trend. It has increased from 460.00 Cr. (Mar 2025) to 525.00 Cr., marking an increase of 65.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Mar 2025) to 15.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 84.00 Cr.. The value appears to be declining and may need further review. It has decreased from 570.00 Cr. (Mar 2025) to 84.00 Cr., marking a decrease of 486.00 Cr..
• For Interest, as of Jun 2025, the value is 63.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 88.00 Cr. (Mar 2025) to 63.00 Cr., marking a decrease of 25.00 Cr..
• For Depreciation, as of Jun 2025, the value is 85.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 87.00 Cr. (Mar 2025) to 85.00 Cr., marking a decrease of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 461.00 Cr.. The value appears to be declining and may need further review. It has decreased from 855.00 Cr. (Mar 2025) to 461.00 Cr., marking a decrease of 394.00 Cr..
• For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 18.00% (Mar 2025) to 24.00%, marking an increase of 6.00%.
• For Net Profit, as of Jun 2025, the value is 349.00 Cr.. The value appears to be declining and may need further review. It has decreased from 699.00 Cr. (Mar 2025) to 349.00 Cr., marking a decrease of 350.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.31. The value appears to be declining and may need further review. It has decreased from 26.62 (Mar 2025) to 13.31, marking a decrease of 13.31.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:08 am

Growth

Last Updated: September 5, 2025, 1:56 pm

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Welspun Corp Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 72.80. This value is within the healthy range. It has increased from 42.45 (Mar 24) to 72.80, marking an increase of 30.35.
• For Diluted EPS (Rs.), as of Mar 25, the value is 72.44. This value is within the healthy range. It has increased from 42.32 (Mar 24) to 72.44, marking an increase of 30.12.
• For Cash EPS (Rs.), as of Mar 25, the value is 62.68. This value is within the healthy range. It has increased from 46.70 (Mar 24) to 62.68, marking an increase of 15.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 283.41. It has increased from 213.92 (Mar 24) to 283.41, marking an increase of 69.49.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 283.41. It has increased from 213.92 (Mar 24) to 283.41, marking an increase of 69.49.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 532.80. It has decreased from 662.68 (Mar 24) to 532.80, marking a decrease of 129.88.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 70.82. This value is within the healthy range. It has increased from 68.94 (Mar 24) to 70.82, marking an increase of 1.88.
• For PBIT / Share (Rs.), as of Mar 25, the value is 57.44. This value is within the healthy range. It has increased from 55.65 (Mar 24) to 57.44, marking an increase of 1.79.
• For PBT / Share (Rs.), as of Mar 25, the value is 63.01. This value is within the healthy range. It has increased from 44.01 (Mar 24) to 63.01, marking an increase of 19.00.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 49.30. This value is within the healthy range. It has increased from 33.41 (Mar 24) to 49.30, marking an increase of 15.89.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 72.73. This value is within the healthy range. It has increased from 42.44 (Mar 24) to 72.73, marking an increase of 30.29.
• For PBDIT Margin (%), as of Mar 25, the value is 13.29. This value is within the healthy range. It has increased from 10.40 (Mar 24) to 13.29, marking an increase of 2.89.
• For PBIT Margin (%), as of Mar 25, the value is 10.78. This value is within the healthy range. It has increased from 8.39 (Mar 24) to 10.78, marking an increase of 2.39.
• For PBT Margin (%), as of Mar 25, the value is 11.82. This value is within the healthy range. It has increased from 6.64 (Mar 24) to 11.82, marking an increase of 5.18.
• For Net Profit Margin (%), as of Mar 25, the value is 9.25. This value is within the healthy range. It has increased from 5.04 (Mar 24) to 9.25, marking an increase of 4.21.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.65. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 13.65, marking an increase of 7.25.
• For Return on Networth / Equity (%), as of Mar 25, the value is 25.66. This value is within the healthy range. It has increased from 19.83 (Mar 24) to 25.66, marking an increase of 5.83.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.90. This value is within the healthy range. It has decreased from 18.49 (Mar 24) to 16.90, marking a decrease of 1.59.
• For Return On Assets (%), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from 9.37 (Mar 24) to 12.52, marking an increase of 3.15.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.28 (Mar 24) to 0.05, marking a decrease of 0.23.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.12. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.12, marking a decrease of 0.21.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.03. It has decreased from 1.28 (Mar 24) to 1.03, marking a decrease of 0.25.
• For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. It has decreased from 1.53 (Mar 24) to 1.33, marking a decrease of 0.20.
• For Quick Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.66, marking a decrease of 0.28.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.08. This value is within the healthy range. It has increased from 2.66 (Mar 24) to 4.08, marking an increase of 1.42.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.87. This value is below the healthy minimum of 20. It has decreased from 11.77 (Mar 24) to 6.87, marking a decrease of 4.90.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.80. This value is below the healthy minimum of 20. It has decreased from 8.96 (Mar 24) to 5.80, marking a decrease of 3.16.
• For Earning Retention Ratio (%), as of Mar 25, the value is 93.13. This value exceeds the healthy maximum of 70. It has increased from 88.23 (Mar 24) to 93.13, marking an increase of 4.90.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.20. This value exceeds the healthy maximum of 70. It has increased from 91.04 (Mar 24) to 94.20, marking an increase of 3.16.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.81. This value is within the healthy range. It has decreased from 5.93 (Mar 24) to 5.81, marking a decrease of 0.12.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.59. This value is within the healthy range. It has decreased from 3.87 (Mar 24) to 3.59, marking a decrease of 0.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 22,725.18. It has increased from 14,454.64 (Mar 24) to 22,725.18, marking an increase of 8,270.54.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 0.83 (Mar 24) to 1.63, marking an increase of 0.80.
• For EV / EBITDA (X), as of Mar 25, the value is 12.23. This value is within the healthy range. It has increased from 8.01 (Mar 24) to 12.23, marking an increase of 4.22.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 0.77 (Mar 24) to 1.63, marking an increase of 0.86.
• For Retention Ratios (%), as of Mar 25, the value is 93.12. This value exceeds the healthy maximum of 70. It has increased from 88.22 (Mar 24) to 93.12, marking an increase of 4.90.
• For Price / BV (X), as of Mar 25, the value is 3.07. This value exceeds the healthy maximum of 3. It has increased from 2.41 (Mar 24) to 3.07, marking an increase of 0.66.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 0.77 (Mar 24) to 1.63, marking an increase of 0.86.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness